PRINCETON, N.J.- Bristol-Myers Squibb Co. plans to double the number of its product launches and has outlined an ambitious research and development strategy.
"We have embarked on an extraordinary journey of discovery and growth at our Pharmaceutical Research Institute (PRI) and in our other medicine businesses," chairman and chief executive officer Charles Heimbold said in a recent daylong appearance before investors and financial analysts.
"Our future as one of the world's great companies depends on our ability to discover, develop and market the best, most innovative, most effective arid most sought-after pharmaceuticals in the world."
Currently, more …
Комментариев нет:
Отправить комментарий